NCT06484075View on ClinicalTrials.gov

Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 21, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Healthy VolunteersAlcohol Use Disorder (AUD)
Interventions
DRUG

Placebo

The placebo will be a tablet, but only containing inert inactive ingredients.

DRUG

Suvorexant

Drug approved for improving sleep

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH